UK’s landmark investigation into gender identity services for children and adolescents has led to Scotland and Wales following England in halting the prescription of puberty blockers. The Cass review revealed lack of evidence supporting the “gender affirming” model of care. In the US, medical organizations such as AAP and Endocrine Society have stood by their guidelines, despite criticisms from the Cass review. Media responses have been polarized, with some outlets supporting the affirming model, while others, like the Wall Street Journal, urge caution. The review has sparked debate within the medical community about the long-term effects of gender treatments and the need for more evidence-based guidelines.
Source link
Gender medicine in the US: how the Cass review failed to land
